LAM SOON (HK) (00411) announces annual performance with a net profit of HK$303 million, representing a 51% year-on-year increase.
Nam Shun (Hong Kong) (00411) announced its financial results for the year ending June 30, 2025, achieving a revenue of $48.2 million.
Lam Soon (HK) (00411) announced its annual performance for the fiscal year ending on June 30, 2025, with a revenue of HK$4.829 billion, which remained relatively stable compared to the previous year. Gross profit was HK$1.119 billion, an increase of 10% year-on-year. Net profit for the year was HK$303 million, a 51% increase compared to the same period last year; earnings per share were HK$1.29, with a proposed final dividend of HK$0.33 per share.
In the fiscal year 2024/25, the group faced challenging market conditions, consumer downgrading, and intense market competition. To maintain sales volume and consolidate market share, the group has made selective price adjustments. The prices of wheat and edible oil have also decreased compared to last year, providing some relief for the group. Flexible procurement strategies and prudent management of operating expenses have played a key role in safeguarding profit margins and profitability. Additionally, the group is actively implementing measures to strengthen its talent pool, enhance digital and R&D infrastructure, and explore new product development to support long-term growth.
Related Articles

US Stock Market Move | Fangdd Network Group Ltd Sponsored ADR Class A(DUO.US) surged 13%, narrowing the month-on-month decline in sales prices of residential properties in top and second-tier cities in August.

US Stock Market Move | Advertising content of its weight-loss drugs under the label has been warned by the FDA. Hims & Hers Health (HIMS.US) dropped more than 7%.

DL HOLDINGS GP (01709) further subscribed to 15.10% Class B membership interests of Carmel Reserve LLC.
US Stock Market Move | Fangdd Network Group Ltd Sponsored ADR Class A(DUO.US) surged 13%, narrowing the month-on-month decline in sales prices of residential properties in top and second-tier cities in August.

US Stock Market Move | Advertising content of its weight-loss drugs under the label has been warned by the FDA. Hims & Hers Health (HIMS.US) dropped more than 7%.

DL HOLDINGS GP (01709) further subscribed to 15.10% Class B membership interests of Carmel Reserve LLC.
